Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
149
天
Gasdermin‐Mediated Pyroptosis: Novel Strategies Against Colorectal Cancer
作者
Kaibo Guo; Yuqian Feng; Jiamin Lu; Nuerbiye Abudurexiti; Xinlei Zhou; Mengfan Wei; Song Zheng展开收起
作者单位
1. Department of Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine Westlake University Hangzhou China; 2. Key Laboratory of Clinical Cancer Pharmacology & Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine Westlake University Hangzhou China; 3. Department of Geriatrics The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine) Hangzhou China; 4. Department of Oncology The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine) Hangzhou China; 5. Department of Oncology, the Fourth School of Clinical Medicine Zhejiang Chinese Medical University Hangzhou China; 6. The Third Clinical Medical School, the Rehabilitation Medical School Zhejiang Chinese Medical University Hangzhou China; 7. School of Medical Technology and Information Engineering Zhejiang Chinese Medical University Hangzhou China展开收起
64
天
145
天
First‐In‐Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck
作者
Nobuaki Matsubara; Ken Saijo; Yasushi Shimizu; Susumu Okano; Kenji Nakano; Naoki Nishio; Tomoyuki Otsuka; Hirofumi Kuno; Takuma Miura; Tomoki Kubota; Hiroki Ikezawa; Yuko Umetsu; Ken Ito; Abraham Apfel; Yuanqing Ye; Yoshitaka Honma展开收起
作者单位
1. Department of Medical Oncology National Cancer Center Hospital East Kashiwa Chiba Japan; 2. Department of Medical Oncology Tohoku University Hospital Sendai Japan; 3. Department of Medical Oncology Hokkaido University Hospital Sapporo Hokkaido Japan; 4. Department of Head and Neck Medical Oncology National Cancer Center Hospital East Kashiwa Chiba Japan; 5. Department of Medical Oncology Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan; 6. Department of Otorhinolaryngology Nagoya University Hospital Nagoya Japan; 7. Department of Medical Oncology Osaka International Cancer Institute Osaka Japan; 8. Department of Diagnostic Radiology National Cancer Center Hospital East Kashiwa Chiba Japan; 9. Japan and Asia Clinical Development Department Eisai Co. Ltd. Tokyo Japan; 10. Clinical Data Science Department Eisai Co. Ltd. Tokyo Japan; 11. Clinical Pharmacology & Translational Research Department Eisai Co. Ltd. Tokyo Japan; 12. Oncology Discovery Department Eisai Co. Ltd. Ibaraki Japan; 13. Clinical Data Science Eisai Inc. Nutley New Jersey USA; 14. Department of Head and Neck, Esophageal Medical Oncology National Cancer Center Hospital Tokyo Japan展开收起
46
天
43
天
Pathophysiological and Molecular Features of DXd ADC ‐Related Interstitial Pneumonitis in Cynomolgus Monkeys
作者
Kazuyoshi Kumagai; Takuma Iguchi; Kentaro Kubota; Ken Sakurai; Yoshimi Tsuchiya; Katsuyoshi Chiba展开收起
作者单位
1. Medicinal Safety Research Laboratories Daiichi Sankyo Co., Ltd. Tokyo Japan; 2. Medicinal Safety Daiichi Sankyo Inc. Basking Ridge New Jersey USA展开收起
149
天
Epithelial YPEL3 Modulates CD8 + T‐Cell Infiltration and Tumor Progression Through CREB1–CXCL16 Signaling in HNSCC
作者
Yalun Li; Yumei Li; Caiyu Sun; Congxian Lu; Gang Chen; Tianshu Zhou; Bei Zhang; Xicheng Song展开收起
作者单位
1. Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital Qingdao University Yantai China; 2. Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation Yantai China; 3. Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases Yantai China; 4. Yantai Key Laboratory of Otorhinolaryngologic Diseases Yantai China; 5. School of Basic Medicine Qingdao University Yantai China; 6. Department of Breast Surgery, Yantai Yuhuangding Hospital Qingdao University Yantai China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天